SYAHRANI, R. A., M. LOUISA, and S. I. WANANDI. “SENSITIVITY OF BREAST CANCER STEM CELLS (CD24-/CD44+) TO DOXORUBICIN IS ASSOCIATED WITH OXIDATIVE STRESS STATUS”. International Journal of Applied Pharmaceutics, Vol. 11, no. 6, Dec. 2019, pp. 91-96, doi:10.22159/ijap.2019.v11s6.33555.